Article info
PDFOriginal research
Performance evaluation of the Biocartis Idylla EGFR Mutation Test using pre-extracted DNA from a cohort of highly characterised mutation positive samples
- Correspondence to Dr Philip Bennett, Sarah Cannon Molecular Diagnostics, HCA Healthcare UK, London, UK; Philip.Bennett{at}hcahealthcare.co.uk
Citation
Performance evaluation of the Biocartis Idylla EGFR Mutation Test using pre-extracted DNA from a cohort of highly characterised mutation positive samples
Publication history
- Received December 15, 2020
- Revised January 11, 2021
- Accepted January 12, 2021
- First published January 29, 2021.
Online issue publication
May 15, 2022
Article Versions
- Previous version (17 March 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.